跳至主要内容
临床试验/IRCT20150101020514N22
IRCT20150101020514N22尚未招募2 期

Safety and efficacy of assessment of Alis collagen drink (containing 4 g hydrolyzed collagen) compared to a control collagen-free drink for improvement of biophysical and ultrasonography skin parameters

Pishgamane Eixire Sabze Arvand Co.0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 55 years(—)
性别
All

入选标准

  • Ages 35 to 55
  • Healthy people with skin type II to V
  • Signing the consent form for participation in the study

排除标准

  • History of using RF, anti aging and intense pulsed light during the past 6 months
  • .Active smoker in last 2 years
  • Pregnancy or lactating
  • Suffering from systemic diseases that affect skin health, such as vascular collagen diseases, diabetes, hypothyroidism, as well as liver and kidney failure.
  • History of taking supplements containing collagen, hyaluronic acid and vitamin C in the last 3 months

研究者

发起方
Pishgamane Eixire Sabze Arvand Co.

相似试验